Thyrotoxicosis is a common disorder, especially in women. The most frequent cause is
Graves' disease (autoimmune hyperthyroidism). Other important causes include toxic …

Background The management guidelines of the American Thyroid Association and
American Association of Clinical Endocrinologists for Graves' disease (GD) include any of …

Context There is little consensus regarding the most appropriate dose of radioiodine (131I)
to be administered to patients with hyperthyroidism. Objective To compare the efficacy of …

Abstract Treatment strategy in Graves' disease firstly requires recovery of euthyroid status by
antithyroid therapy. Treatment modalities, precautions, advantages and side-effects are to …

Background Persistent or recurrent hyperthyroidism after treatment with radioactive iodine
(RAI) is common and many patiedlxnts require either additional doses or surgery before they …

Objective Little data is in existence about the most cost-effective primary treatment for
Graves' disease. We performed a cost–utility analysis comparing radioactive iodine (RAI) …

Introduction Autoimmune reactions in Graves' disease (GD) occur not only in the thyroid
gland, but also in the orbital connective tissue, eyelids, extraocular muscles. The occurrence …

Abstract Background: In China, use of radioiodine therapy is problematic because of the
need for lifelong levothyroxine substitution. Our aim was to find an optimum dosing strategy …

Background: Graves' disease is commonly treated with curative intent using radioactive
iodine (RAI). While higher doses have been shown to increase success rates, more …

Objective To assess the predictability of outcome and evaluate the factors that may lead to
treatment failure in patients with Graves' disease who are treated with a single dose of …